Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priscilla L Yang

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
ACS Infectious Diseases|June 1, 2021
Antiviral TherapeuticsPriscilla L Yang
Antiviral Research|February 14, 2016
Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA virusesMargot Carocci, Priscilla L Yang
Antiviral Research|December 25, 2022
Targeted protein degradation as an antiviral approachAntara Chakravarty, Priscilla L Yang
Journal of Virology|April 26, 2012
Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assemblyMelissanne de Wispelaere, Priscilla L Yang
Annual Review of Virology|July 1, 2021
Small-Molecule Inhibition of Viral Fusion GlycoproteinsHan-Yuan Liu, Priscilla L Yang
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
c-Src protein kinase inhibitors block assembly and maturation of dengue virusJ J H Chu, Priscilla L Yang
Journal of the American Chemical Society|March 24, 2009
Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid metabolite profilingMary A Rodgers, Alan Saghatelian, Priscilla L Yang
Nature Reviews. Cancer|December 24, 2008
Targeting cancer with small molecule kinase inhibitorsJianming Zhang, Priscilla L Yang, Nathanael S Gray
Journal of Virology|October 1, 2010
Peptide inhibitors of flavivirus entry derived from the E protein stemAaron G Schmidt, Priscilla L Yang, Stephen C Harrison
Plos Pathogens|April 14, 2010
Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediateAaron G Schmidt, Priscilla L Yang, Stephen C Harrison
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
ACS Infectious Diseases|June 1, 2021
Antiviral TherapeuticsPriscilla L Yang
Antiviral Research|February 14, 2016
Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA virusesMargot Carocci, Priscilla L Yang
Antiviral Research|December 25, 2022
Targeted protein degradation as an antiviral approachAntara Chakravarty, Priscilla L Yang
Journal of Virology|April 26, 2012
Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assemblyMelissanne de Wispelaere, Priscilla L Yang
Annual Review of Virology|July 1, 2021
Small-Molecule Inhibition of Viral Fusion GlycoproteinsHan-Yuan Liu, Priscilla L Yang
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
c-Src protein kinase inhibitors block assembly and maturation of dengue virusJ J H Chu, Priscilla L Yang
Journal of the American Chemical Society|March 24, 2009
Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid metabolite profilingMary A Rodgers, Alan Saghatelian, Priscilla L Yang
Nature Reviews. Cancer|December 24, 2008
Targeting cancer with small molecule kinase inhibitorsJianming Zhang, Priscilla L Yang, Nathanael S Gray
Journal of Virology|October 1, 2010
Peptide inhibitors of flavivirus entry derived from the E protein stemAaron G Schmidt, Priscilla L Yang, Stephen C Harrison
Plos Pathogens|April 14, 2010
Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediateAaron G Schmidt, Priscilla L Yang, Stephen C Harrison
Pageof 6